GSK Can't Shake Calif. County's Avandia False Ad Claims
Law360, New York (February 26, 2014, 3:39 PM EST) -- A Pennsylvania federal judge on Tuesday denied GlaxoSmithKline PLC's bid to partially dismiss false advertising claims brought by Santa Clara County, Calif., over GSK's diabetes medication Avandia, rejecting its argument that the claims must be based on false advertising displayed within the county.
GSK had argued that a release included in a settlement between the company and the California attorney general in November 2012 that excluded claims for Santa Clara County residents limited the claims to residents exposed to false advertising within the county, but U.S. District Judge Cynthia M. Rufe said the company's interpretation of the release was inconsistent with...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!